Quotient Limited to Participate in the Cowen 42nd Annual Health Care Conference

Rhea-AI Summary

Quotient Limited (NASDAQ:QTNT) announced its participation in the Cowen 42nd Annual Health Care Conference, with a fireside chat scheduled for March 9, 2022, at 11:00 am ET. The company focuses on transfusion diagnostics and offers MosaiQ, an innovative multiplex microarray technology. This platform allows for fully automated testing across various modalities, aiming to enhance laboratory efficiency, clinical practice, and cost savings globally. Quotient operates from locations in Switzerland, Scotland, and Pennsylvania.

JERSEY, Channel Islands, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the management team will participate in the Cowen 42nd Annual Health Care Conference. As part of the conference, the Company will be conducting a fireside chat on Wednesday, March 9, 2022 at 11:00am ET.

About Quotient Limited

Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. MosaiQ is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and create operational cost savings to laboratories around the world. Quotient's operations are based in Eysins, Switzerland, Edinburgh, Scotland and Newtown, Pennsylvania.

The Quotient logo, Quotient MosaiQ and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.

Contact: IR@quotientbd.com; +41 22 545 52 26

FAQ

When is Quotient Limited's fireside chat at the Cowen 42nd Annual Health Care Conference?

Quotient Limited's fireside chat is scheduled for March 9, 2022, at 11:00 am ET.

What technology does Quotient Limited offer?

Quotient Limited offers MosaiQ, a fully automated multiplex microarray technology for diagnostics.

Where are Quotient Limited's operations based?

Quotient Limited's operations are based in Eysins, Switzerland; Edinburgh, Scotland; and Newtown, Pennsylvania.

What is the focus of Quotient Limited?

Quotient Limited specializes in transfusion diagnostics aimed at improving clinical practices and laboratory efficiencies.